Dermatology · Stanford, CA
NPI
1235454182
Since 2010
Specialty
Dermatology
Code 207N00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
300 Pasteur Dr
Stanford, CA, 94305
Phone (650) 723-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$88K
1,397 services
Medicare patients, 2024
421
Average age 72
Drug cost, 2024
$3.9M
1,862 prescriptions
Company payments, 2025
$138K
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew A Lewis was code 99214 (office e&m - established), 345 times for 237 patients. In total Matthew A Lewis billed 1,397 services in 29 codes, and Medicare paid $88K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 345 | 237 | $87.01 | $30K |
| 17003 Destruction Skin Lesion | Office | 316 | 51 | $1.80 | $569 |
| 99215 Office E&M - Established | Office | 196 | 112 | $149.84 | $29K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 102 | 86 | $14.69 | $1,499 |
| 17000 Destruction Skin Lesion | Office | 101 | 70 | $50.27 | $5,078 |
| 99213 Office E&M - Established | Office | 65 | 53 | $46.59 | $3,028 |
| 11102 Skin Biopsy | Office | 49 | 43 | $26.71 | $1,309 |
| 99204 Office E&M - New | Office | 40 | 40 | $113.84 | $4,554 |
| 99233 Hospital E&M - Subsequent | Facility | 31 | 20 | $102.89 | $3,190 |
| 99203 Office E&M - New | Office | 23 | 23 | $62.81 | $1,445 |
| 11103 Skin Biopsy | Office | 20 | 14 | $19.82 | $396 |
| 99222 Hospital E&M - Initial | Facility | 17 | 16 | $116.78 | $1,985 |
By year: 2022 $55K for 1,058 services; 2023 $74K for 1,335 services; 2024 $88K for 1,397 services.
Medicare prescription drug claims, 2024
In 2024, the drug Matthew A Lewis prescribed most often to Medicare patients was Dupixent Syringe (Dupilumab), with 142 prescriptions and refills. In total Matthew A Lewis wrote 1,862 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dupixent Syringe Dupilumab | 142 | 142 | 17 | $526K |
| Dupixent Pen Dupilumab | 130 | 134 | 17 | $564K |
| Triamcinolone Acetonide Generic | 88 | 109 | 54 | $2,064 |
| Minoxidil Generic | 67 | 163 | 26 | $866 |
| Fluocinonide Generic | 63 | 79 | 34 | $2,706 |
| Prednisone Generic | 63 | 72 | 23 | $548 |
| Ketoconazole Generic | 60 | 62 | 21 | $1,023 |
| Clobetasol Propionate Generic | 52 | 65 | 21 | $4,102 |
| Taltz Autoinjector Ixekizumab | 46 | 51 | Under 11 | $373K |
| Mycophenolate Mofetil Generic | 44 | 60 | 11 | $26K |
| Doxycycline Hyclate Generic | 41 | 45 | 15 | $1,597 |
| Hydroxychloroquine Sulfate Generic | 40 | 78 | Under 11 | $1,130 |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 36 | 36 | Under 11 | $454K |
| Hydrocortisone Generic | 36 | 36 | 18 | $190 |
| Clindamycin Phosphate Generic | 33 | 40 | 12 | $1,752 |
Brand drugs: - claims; generic drugs: 1,238 claims; opioid claims: 46.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew A Lewis $138K ($138K in general payments such as food, travel and fees) from 4 companies. The largest payer was Galderma Laboratories, L.P. with $53K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.